The Medicare DMEPOS Competitive
Bidding Program was established by the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 ("Medicare Modernization
Act" or "MMA"). Section 302 of the MMA amended Section 1847 of the
Social Security Act to establish the competitive acquisition
program and define program requirements. Under the MMA, the DMEPOS
Competitive Bidding Program was to be phased in so that competition
under the program would first occur in 10 areas in 2007. The
Centers for Medicare & Medicaid Services (CMS) completed the
rulemaking process for the competitive acquisition of DMEPOS items
and services in 42 CFR Parts 411 and 414 published in the Federal
Register Volume 72 on April 10, 2007. CMS conducted the Round 1
competition in 10 areas and for 10 DMEPOS product categories, and
implemented the program on July 1, 2008. The Medicare Improvements
for Patients and Providers Act of 2008 (MIPPA), enacted on July 15,
2008, made limited changes to the Competitive Bidding Program,
including termination of existing contracts that were in effect and
a requirement to re-bid Round 1. As required by MIPPA, CMS
conducted the competition for the Round 1 Rebid in 2009. The Round
1 Rebid contracts and prices became effective on January 1, 2011.
The Affordable Care Act (ACA), enacted on March 23, 2010, expanded
the Round 2 competition by adding an additional 21 MSAs, bringing
the total MSAs for Round 2 to 91. The competition for Round 2 began
in December 2011. CMS also began a competition for National Mail
Order of Diabetic Testing Supplies (DTS) at the same time as Round
2. The Round 2 and National Mail-Order contracts and prices were
implemented on July 1, 2013. The competition for the Round 1
Recompete began in August of 2012. The Round 1 Recompete contracts
and prices became effective on January 1, 2014 and will expire on
December 31, 2016. Round 2 and National Mail-Order contracts and
prices will expire on June 30, 2016. The most recent approval for
this information collection request (ICR) was issued by OMB on June
10, 2013. That ICR included the estimated burden to collect the
information in bidding Forms A and B for the Round 1 Recompete. We
are now seeking approval to collect the information in Forms A and
B for competitions that will occur before 2017.
PL:
Pub.L. 108 - 173 302(b)(1) Name of Law: Payment for durable
medical equipment; competitive acquisition of certain items and
services
PL:
Pub.L. 110 - 275 154 Name of Law: Delay in and Reform of
Medicare DMEPOS Competitive Acquisition Program
PL: Pub.L. 110 - 275 154 Name of Law: Delay
in and Reform of Medicare DMEPOS Competitive Acquisition
Program
The ICR has been revised to
account for the burden associated with Forms A and B. The burden
has also been revised accordingly.
$2,310,864
No
No
Yes
No
No
Uncollected
William Parham
4107864669
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
Form CMS-10169 Bidding Form (Form B)
508_Crosswalk for Form B PRA 6-30-14.pdf
508_CMS-10169_Supporting_Statement_Part_A.docx
Bidding Form (Form B)